BioMedEcon Health Economics and Outcomes Research has just delivered an oral presentation summarizing the results of a pioneering study that compares healthcare costs of patients with obsessive-compulsive disorder (OCD) to those of patients with depression. This presentation was delivered at the 31st Annual Meeting of the Society of General and Internal Medicine (SGIM) held in Pittsburgh, Penn. This study, which was funded by Jazz Pharmaceuticals, Inc.
Popularity: unranked [?]
Related posts:
- BioMedEcon Reports 200% Higher Outpatient Medical Costs Among Patients With Obsessive-Compulsive Disorder Compared To Matched Patients With Depression
- Female Cardiovascular Patients With Depression Incur Higher Health Care Costs
- Rexahn Reports Positive Top-line Phase IIa Data For SerdaxinTM In Patients With Major Depressive Disorder (MDD)
- Link Between Depression And Higher Death Rates From All Causes Among Elderly With Diabetes
- Why Omega-3s Seem To Improve Mood
Comments
No Responses to “BioMedEcon Reports Three Times Higher Healthcare Costs Among Patients With Obsessive-Compulsive Disorder Compared To Patients With Depression”